Exercise of Authority Under Section 212(d)(3)(B)(i) of the Immigration and Nationality Act, 34770-34771 [E8-13638]
Download as PDF
<![CDATA[
34770
Federal Register / Vol. 73, No. 118 / Wednesday, June 18, 2008 / Notices
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Modulation of Iron
Deposition in SCD and Other
Hemoglobinopathies.
Date: July 9, 2008.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 755, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, ls38oz@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 11, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–13701 Filed 6–17–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
rwilkins on PROD1PC63 with NOTICES
National Institutes of Health
Prospective Grant of Exclusive
License: Geldanamycin Derivative and
Method of Treating Viral Infections
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
VerDate Aug<31>2005
18:01 Jun 17, 2008
Jkt 214001
Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
Part 404.7(a)(1)(i), that the National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an exclusive
patent license to practice the invention
embodied in U.S. Patent No. 6,890,917,
issued May 10, 2005, entitled
‘‘Geldanamycin Derivative and Method
of Treating Cancer Using Same’’ [E–
050–2000/0–US–15] and foreign
equivalents, to Avira Therapeutics, LLC,
having a place of business in Menlo
Park, California. The patent rights in
these inventions have been assigned to
the United States of America.
The prospective exclusive license
territory may be worldwide, and the
field of use may be limited to the use
of the manufacture, use, distribution
and sale of 17–DMAG, an analog of
geldanamycin, as a therapeutic to
inhibit the influenza virus, respiratory
syncytial virus (RSV) and dengue virus.
This replaces a notice published in 73
FR 31702 on Tuesday, June 3, 2008,
which omitted the name of the potential
licensee.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
August 18, 2008 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Adaku Madu, J.D.,
Technology Licensing Specialist, Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
5560; Facsimile: (301) 402–0220; E-mail:
madua@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
technology relates to novel cytotoxic
compounds derived from 17aminoalkylamino-substituted
geldanamycin and pharmaceutical
compositions thereof. In particular, this
invention refers to 17-(dimehtylamino)
propylamino-geldanamycin, 17(dimethylamino) ethylaminogeldanamycin, and the hydrochloride
salt of 17-(dimethylamino) ethylaminogeldanamycin (DMAG and analogs).
These compounds are Hsp90 inhibitors.
Hsp90 inhibition downregulates B–Raf,
decreases cell proliferation and reduces
activation of the MEK/ERK pathways in
some cells. Hsp90 plays an essential
role in maintaining stability and activity
in its client proteins. Hsp90 inhibitors
interfere with diverse signaling
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
pathways by destabilizing and
attenuating activity of such proteins,
and thus exhibit antitumor activity.
Specifically, 17–DMAG shows
cytotoxicity against a number of human
colon and lung cell lines, specific
melanoma, renal and breast lines, and
potentially against various viral
infections. In addition, these
compounds appear to have favorable
pharmaceutical properties including
oral activity and improved watersolubility.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR Part 404.7. The
prospective exclusive license may be
granted unless within sixty (60) days
from the date of this published notice,
the NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR 404.7.
Applications for a license in the field
of use filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive license.
Comments and objections submitted to
this notice will not be made available
for public inspection and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: June 9, 2008.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E8–13671 Filed 6–17–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
DEPARTMENT OF STATE
Office of the Secretary
Exercise of Authority Under Section
212(d)(3)(B)(i) of the Immigration and
Nationality Act
Office of the Secretary, DHS;
Office of the Secretary, DOS.
ACTION: Notice of Determination.
AGENCY:
This determination is effective
June 3, 2008.
DATES:
Authority: 8 U.S.C. 1182(d)(3)(B)(i).
The Secretary of Homeland Security
and the Secretary of State, following
consultations with the Attorney
General, hereby conclude, as a matter of
E:\FR\FM\18JNN1.SGM
18JNN1
rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 73, No. 118 / Wednesday, June 18, 2008 / Notices
discretion in accordance with our
respective authorities under section
212(d)(3)(B)(i) of the Immigration and
Nationality Act (INA), 8 U.S.C.
1182(d)(3)(B)(i), as amended by the
Consolidated Appropriations Act, 2008
(CAA), Public Law 110–161, Div. J,
section 691(a), 121 Stat. 1844, 2364
(December 26, 2007), as well as the
foreign policy and national security
interests deemed relevant in these
consultations, that section 212(a)(3)(B)
of the INA, excluding subclause (i)(II),
shall not apply with respect to an alien
not otherwise covered by the automatic
relief provisions of section 691(b) of the
CAA, for any activity or association
relating to appropriate groups affiliated
with the Montagnards, provided that
there is no reason to believe that the
relevant terrorist activities of the alien
or the recipients were targeted against
noncombatant persons, and further
provided that the alien satisfies the
relevant agency authority that the alien:
(a) Is seeking a benefit or protection
under the INA and has been determined
to be otherwise eligible for the benefit
or protection;
(b) Has undergone and passed
relevant background and security
checks;
(c) Has fully disclosed, in all relevant
applications and interviews with U.S.
government representatives and agents,
the nature and circumstances of each
activity or association falling within the
scope of section 212(a)(3)(B) of the INA;
(d) Poses no danger to the safety and
security of the United States; and
(e) Is warranted to be exempted from
the relevant inadmissibility provision
by the totality of the circumstances.
Implementation of this determination
will be made by U.S. Citizenship and
Immigration Services (USCIS), in
consultation with U.S. Immigration and
Customs Enforcement (ICE), or by U.S.
consular officers, as applicable, who
shall ascertain, to their satisfaction, and
in their discretion, that the particular
applicant meets the criteria set forth
above.
This exercise of authority may be
revoked as a matter of discretion and
without notice at any time with respect
to any and all persons subject to it. Any
determination made under this exercise
of authority as set out above shall apply
to any subsequent benefit or protection
application, unless such exercise of
authority has been revoked.
This exercise of authority shall not be
construed to prejudice, in any way, the
ability of the U.S. government to
commence subsequent criminal or civil
proceedings in accordance with U.S.
law involving any beneficiary of this
exercise of authority (or any other
person). This exercise of authority is not
VerDate Aug<31>2005
19:32 Jun 17, 2008
Jkt 214001
intended to create any substantive or
procedural right or benefit that is legally
enforceable by any party against the
United States or its agencies or officers
or any other person.
In accordance with section
212(d)(3)(B)(ii) of the INA, 8 U.S.C.
1182(d)(3)(B)(ii), a report on the aliens
to whom this exercise of authority is
applied, on the basis of case-by-case
decisions by the Department of
Homeland Security or by the
Department of State, shall be provided
to the specified congressional
committees not later than 90 days after
the end of the fiscal year.
This determination is based on an
assessment related to the national
security and foreign policy interests of
the United States as they apply to the
particular persons described herein and
shall not have any application with
respect to other persons or to other
provisions of U.S. law.
Dated: June 3, 2008.
Michael Chertoff,
Secretary of Homeland Security.
Condoleezza Rice,
Secretary of State.
[FR Doc. E8–13638 Filed 6–17–08; 8:45 am]
BILLING CODE 9111–97–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
DEPARTMENT OF STATE
Office of the Secretary
Exercise of Authority Under Section
212(d)(3)(B)(i) of the Immigration and
Nationality Act
Office of the Secretary, DHS;
Office of the Secretary, DOS.
ACTION: Notice of determination.
AGENCY:
This determination is effective
June 3, 2008.
DATES:
Authority: 8 U.S.C. 1182(d)(3)(B)(i).
The Secretary of Homeland Security
and the Secretary of State, following
consultations with the Attorney
General, hereby conclude, as a matter of
discretion in accordance with our
respective authorities under section
212(d)(3)(B)(i) of the Immigration and
Nationality Act (INA), 8 U.S.C.
1182(d)(3)(B)(i), as amended by the
Consolidated Appropriations Act, 2008
(CAA), Public Law 110–161, Div. J,
section 691(a), 121 Stat. 1844, 2364
(December 26, 2007), as well as the
foreign policy and national security
interests deemed relevant in these
consultations, that section 212(a)(3)(B)
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
34771
of the INA, excluding subclause (i)(II),
shall not apply with respect to an alien
not otherwise covered by the automatic
relief provisions of section 691(b) of the
CAA, for any activity or association
relating to the Karen National Union/
Karen National Liberation Army (KNU/
KNLA), provided that there is no reason
to believe that the relevant terrorist
activities of the alien or the recipients
were targeted against noncombatant
persons, and further provided that the
alien satisfies the relevant agency
authority that the alien:
(a) Is seeking a benefit or protection
under the INA and has been determined
to be otherwise eligible for the benefit
or protection;
(b) Has undergone and passed
relevant background and security
checks;
(c) Has fully disclosed, in all relevant
applications and interviews with U.S.
government representatives and agents,
the nature and circumstances of each
activity or association falling within the
scope of section 212(a)(3)(B) of the INA;
(d) Poses no danger to the safety and
security of the United States; and
(e) Is warranted to be exempted from
the relevant inadmissibility provision
by the totality of the circumstances.
Implementation of this determination
will be made by U.S. Citizenship and
Immigration Services (USCIS), in
consultation with U.S. Immigration and
Customs Enforcement (ICE), or by U.S.
consular officers, as applicable, who
shall ascertain, to their satisfaction, and
in their discretion, that the particular
applicant meets the criteria set forth
above.
This exercise of authority may be
revoked as a matter of discretion and
without notice at any time with respect
to any and all persons subject to it. Any
determination made under this exercise
of authority as set out above shall apply
to any subsequent benefit or protection
application, unless such exercise of
authority has been revoked.
This exercise of authority shall not be
construed to prejudice, in any way, the
ability of the U.S. government to
commence subsequent criminal or civil
proceedings in accordance with U.S.
law involving any beneficiary of this
exercise of authority (or any other
person). This exercise of authority is not
intended to create any substantive or
procedural right or benefit that is legally
enforceable by any party against the
United States or its agencies or officers
or any other person.
In accordance with section
212(d)(3)(B)(ii) of the INA, 8 U.S.C.
1182(d)(3)(B)(ii), a report on the aliens
to whom this exercise of authority is
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 73, Number 118 (Wednesday, June 18, 2008)]
[Notices]
[Pages 34770-34771]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13638]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Office of the Secretary
DEPARTMENT OF STATE
Office of the Secretary
Exercise of Authority Under Section 212(d)(3)(B)(i) of the
Immigration and Nationality Act
AGENCY: Office of the Secretary, DHS; Office of the Secretary, DOS.
ACTION: Notice of Determination.
-----------------------------------------------------------------------
DATES: This determination is effective June 3, 2008.
Authority: 8 U.S.C. 1182(d)(3)(B)(i).
The Secretary of Homeland Security and the Secretary of State,
following consultations with the Attorney General, hereby conclude, as
a matter of
[[Page 34771]]
discretion in accordance with our respective authorities under section
212(d)(3)(B)(i) of the Immigration and Nationality Act (INA), 8 U.S.C.
1182(d)(3)(B)(i), as amended by the Consolidated Appropriations Act,
2008 (CAA), Public Law 110-161, Div. J, section 691(a), 121 Stat. 1844,
2364 (December 26, 2007), as well as the foreign policy and national
security interests deemed relevant in these consultations, that section
212(a)(3)(B) of the INA, excluding subclause (i)(II), shall not apply
with respect to an alien not otherwise covered by the automatic relief
provisions of section 691(b) of the CAA, for any activity or
association relating to appropriate groups affiliated with the
Montagnards, provided that there is no reason to believe that the
relevant terrorist activities of the alien or the recipients were
targeted against noncombatant persons, and further provided that the
alien satisfies the relevant agency authority that the alien:
(a) Is seeking a benefit or protection under the INA and has been
determined to be otherwise eligible for the benefit or protection;
(b) Has undergone and passed relevant background and security
checks;
(c) Has fully disclosed, in all relevant applications and
interviews with U.S. government representatives and agents, the nature
and circumstances of each activity or association falling within the
scope of section 212(a)(3)(B) of the INA;
(d) Poses no danger to the safety and security of the United
States; and
(e) Is warranted to be exempted from the relevant inadmissibility
provision by the totality of the circumstances.
Implementation of this determination will be made by U.S.
Citizenship and Immigration Services (USCIS), in consultation with U.S.
Immigration and Customs Enforcement (ICE), or by U.S. consular
officers, as applicable, who shall ascertain, to their satisfaction,
and in their discretion, that the particular applicant meets the
criteria set forth above.
This exercise of authority may be revoked as a matter of discretion
and without notice at any time with respect to any and all persons
subject to it. Any determination made under this exercise of authority
as set out above shall apply to any subsequent benefit or protection
application, unless such exercise of authority has been revoked.
This exercise of authority shall not be construed to prejudice, in
any way, the ability of the U.S. government to commence subsequent
criminal or civil proceedings in accordance with U.S. law involving any
beneficiary of this exercise of authority (or any other person). This
exercise of authority is not intended to create any substantive or
procedural right or benefit that is legally enforceable by any party
against the United States or its agencies or officers or any other
person.
In accordance with section 212(d)(3)(B)(ii) of the INA, 8 U.S.C.
1182(d)(3)(B)(ii), a report on the aliens to whom this exercise of
authority is applied, on the basis of case-by-case decisions by the
Department of Homeland Security or by the Department of State, shall be
provided to the specified congressional committees not later than 90
days after the end of the fiscal year.
This determination is based on an assessment related to the
national security and foreign policy interests of the United States as
they apply to the particular persons described herein and shall not
have any application with respect to other persons or to other
provisions of U.S. law.
Dated: June 3, 2008.
Michael Chertoff,
Secretary of Homeland Security.
Condoleezza Rice,
Secretary of State.
[FR Doc. E8-13638 Filed 6-17-08; 8:45 am]
BILLING CODE 9111-97-P
